产品名称 | NebuSelect™ Recombinant Mouse TNFRSF12A/TWEAKR, hFc-tag |
---|---|
目录号 | NBL-241997 |
别名 | TNFRSF12A/TWEAKR; FGF-inducible 14; Fgfrp2; TNFRSF12A; FN14; CD266; TWEAKR |
外观 | see COA |
分子量 | Glu28-Per80 |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | Q9CR75 |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-241997-100ug | 100ug | Inquire | Inquire | |
NBL-241997-1mg | 1mg | Inquire | Inquire | |
NBL-241997-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Mouse TNFRSF12A/TWEAKR, hFc-tag
Catalog#:
NBL-241997
Description:
NebuSelect™ Recombinant Mouse TNFRSF12A/TWEAKR, hFc-tag(Cat#NBL-241997) is expressed in HEK293 with hFc tag at the N-Terminus.It contains Glu28-Per80.
Species:
Mouse
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 32.8 kDa. Due to glycosylation, the protein migrates to 40-50 kDa based on Bis-Tris PAGE result.
Target Name:
TNFRSF12A/TWEAKR; FGF-inducible 14; Fgfrp2; TNFRSF12A; FN14; CD266; TWEAKR
Target Information:
Thyroid cancer (TC) is the most well-known endocrine neoplasia as well as a common malignant tumor in the head and neck.TNFRSF12A expression may be a potential useful prognostic molecular biomarker of bad survival in thyroid cancer, in addition, PPAR signaling pathway, insulin signaling pathway, mTOR signaling pathway may be the key pathway controlled by TNFRSF12A in thyroid cancer. Further experimental ought to be performed to demonstrate the biologic effect of TNFRSF12A.
Amino Acid Sequence:
Glu28-Per80
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.